Skip to main content
. 2011 Sep 19;11:707. doi: 10.1186/1471-2458-11-707

Table 4.

Effect of Birmingham Own Health® Intervention on serum cholesterol among people with diabetes

Intervention Control Multivariate linear regression
coefficients (95%CI)
N 239 1961

Mean age (years) (SD) 63.1 (11.7) 64.4 (10.9) -0.001 (-0.005, 0.002)

Males (n (%)) 129 (54.0) 1024 (52.2) -0.15 (-0.22, -0.08)

Smoking status
Never smoker 87 (36.4%) 824 (42.0) 1.0
Ex-smoker 92 (38.5%) 906 (46.2) -0.03 (-0.11, 0.04)
Current smoker 29 (12.1% 231 (11.8) 0.01 (-0.10, 0.12)
Unknown 31 (13.0%) -

Length of follow-up (days)
Mean (SD) 322.7 (134.4) 330.4 (122.9) -0.0001 (-0.0004, 0.0002)
Median (IQR) 313 (215, 419) 343 (235, 405)

Baseline serum cholesterol (mmol/l) Mean (SD) 4.3 (1.0) 4.4 (1.0) 0.60 (0.56, 0.63)
Sub-groups (n (%))
< 4 mmol/l 88 (36.8%) 656 (33.5%)
4.0-4.9 mmol/l 82 (34.3%) 787 (40.1%)
5.0-5.9 mmol/l 46 (19.2%) 310 (15.8%)
6.0-6.9 mmol/l 9 (3.8%) 75 (3.8%)
> 7.0 mmol/l 3 (1.3%) 33 (1.7%)

Final serum cholesterol (mmol/l) (mean) (SD) 4.1 (1.1) 4.3 (1.0)

Mean change in serum cholesterol (mmol/l) (SD) -0.2 (1.0) -0.1 (0.9)

Difference in final serum cholesterol (intervention - control) (95% CI) -0.2 (-0.3, -0.0)

Adjusted mean difference in final serum cholesterol between intervention and control (mmol/l)(95%CI)* -0.1 (-0.2, -0.1)

Adjusted mean difference in final serum cholesterol between intervention and control by sub-group of baseline values (mmol/l) (95%CI)
< 4 mmol/l 0.0 (-0.2, 0.2)
4.0-4.9 mmol/l -0.3 (-0.5, -0.1)
5.0-5.9 mmol/l -0.0 (-0.3, -0.3)
6.0-6.9 mmol/l -0.1 (-0.9, 0.7)
> 7.0 mmol/l -0.7 (-2.6, 1.2)

* adjusted for age, sex, baseline values, smoking status, length of follow-up